/*! Copyright (c) 2018 Jed Watson. Licensed under the MIT License (MIT), see http://jedwatson.github.io/classnames */ /*! * Select2 4.1.0-rc.0 * https://select2.github.io * * Released under the MIT license * https://github.com/select2/select2/blob/master/LICENSE.md */ /*! * The buffer module from node.js, for the browser. * * @author Feross Aboukhadijeh * @license MIT */ /*! * clipboard.js v2.0.11 * https://clipboardjs.com/ * * Licensed MIT © Zeno Rocha */ /*! * html2canvas 1.4.1 * Copyright (c) 2022 Niklas von Hertzen * Released under MIT License */ /*! * is-plain-object * * Copyright (c) 2014-2017, Jon Schlinkert. * Released under the MIT License. */ /*! * jQuery Mousewheel 3.1.13 * * Copyright jQuery Foundation and other contributors * Released under the MIT license * http://jquery.org/license */ /*! * Parsley.js * Version 2.9.2 - built Tue, Dec 10th 2019, 6:18 pm * http://parsleyjs.org * Guillaume Potier - * Marc-Andre Lafortune - * MIT Licensed */ /*! ***************************************************************************** Copyright (c) Microsoft Corporation. Permission to use, copy, modify, and/or distribute this software for any purpose with or without fee is hereby granted. THE SOFTWARE IS PROVIDED "AS IS" AND THE AUTHOR DISCLAIMS ALL WARRANTIES WITH REGARD TO THIS SOFTWARE INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS. IN NO EVENT SHALL THE AUTHOR BE LIABLE FOR ANY SPECIAL, DIRECT, INDIRECT, OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, WHETHER IN AN ACTION OF CONTRACT, NEGLIGENCE OR OTHER TORTIOUS ACTION, ARISING OUT OF OR IN CONNECTION WITH THE USE OR PERFORMANCE OF THIS SOFTWARE. ***************************************************************************** */ /*! ieee754. BSD-3-Clause License. Feross Aboukhadijeh */ /*! safe-buffer. MIT License. Feross Aboukhadijeh */ /** * @license * Lodash * Copyright OpenJS Foundation and other contributors * Released under MIT license * Based on Underscore.js 1.8.3 * Copyright Jeremy Ashkenas, DocumentCloud and Investigative Reporters & Editors */ /** * @license React * react-dom-server-legacy.browser.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** * @license React * react-dom-server.browser.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** * @license React * react-dom.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** * @license React * react-jsx-runtime.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** * @license React * react.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** * @license React * scheduler.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** * @license React * use-sync-external-store-shim.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** * @license almond 0.3.3 Copyright jQuery Foundation and other contributors. * Released under MIT license, http://github.com/requirejs/almond/LICENSE */ /** @license React v16.13.1 * react-is.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /** @license React v17.0.2 * react-is.production.min.js * * Copyright (c) Facebook, Inc. and its affiliates. * * This source code is licensed under the MIT license found in the * LICENSE file in the root directory of this source tree. */ /**! @license handlebars v4.7.8 Copyright (C) 2011-2019 by Yehuda Katz Permission is hereby granted, free of charge, to any person obtaining a copy of this software and associated documentation files (the "Software"), to deal in the Software without restriction, including without limitation the rights to use, copy, modify, merge, publish, distribute, sublicense, and/or sell copies of the Software, and to permit persons to whom the Software is furnished to do so, subject to the following conditions: The above copyright notice and this permission notice shall be included in all copies or substantial portions of the Software. THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM, OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE. */ //! Copyright (c) JS Foundation and other contributors //! github.com/moment/moment-timezone //! license : MIT //! moment-timezone-utils.js //! moment-timezone.js //! moment.js //! moment.js locale configuration //! version : 0.5.40 //! version : 0.5.41 MOD GRF 1-29 (Tetrasubstituted 29-Amino Acid Peptide Hormone) 2 mg de Deus Medical: Beneficios y Uso – Merch

Merch

CUSTOM MERCH

MOD GRF 1-29 (Tetrasubstituted 29-Amino Acid Peptide Hormone) 2 mg de Deus Medical: Beneficios y Uso

/ Nekategorizirano / By

El MOD GRF 1-29 (Tetrasubstituted 29-Amino Acid Peptide Hormone) de 2 mg de Deus Medical es un péptido de gran relevancia en el ámbito de la medicina deportiva y la terapia hormonal. Este péptido sintético, diseñado para estimular la liberación de hormona de crecimiento, es utilizado frecuentemente por atletas y personas interesadas en mejorar su rendimiento físico y recuperación muscular. Si estás interesado en adquirir este producto en España, puedes consultar el precio MOD GRF 1-29 (Tetrasubstitued 29-Amino Acid Peptide Hormone) 2 mg Deus Medical en España para obtener más información sobre su disponibilidad y coste.

¿Qué es el MOD GRF 1-29?

El MOD GRF 1-29 es un péptido análogo de la hormona liberadora de hormona de crecimiento (GHRH). Su principal función es inducir la glándula pituitaria a aumentar la producción de hormona de crecimiento, lo que puede tener múltiples beneficios en el rendimiento deportivo y la salud en general.

Beneficios del MOD GRF 1-29

  • Aumento de la masa muscular: Estimula la síntesis de proteínas, lo que promueve el crecimiento muscular.
  • Mejora de la recuperación: Acelera la recuperación de lesiones y la fatiga muscular después de entrenamientos intensos.
  • Reducción de grasa corporal: Ayuda a mobilizar la grasa almacenada y a mejorar la composición corporal.
  • Incremento de energía: Mejora el rendimiento físico al aumentar la resistencia y energía durante los entrenamientos.

Instrucciones de uso

El MOD GRF 1-29 generalmente se administra mediante inyección subcutánea. Es esencial seguir las indicaciones del fabricante y consultar con un profesional de la salud antes de comenzar cualquier ciclo. Un uso típico puede incluir:

  1. Administración de una dosis de 1 a 2 mg una o dos veces al día, dependiendo de los objetivos individuales.
  2. Mantener un horario regular y combinarlo con un programa de entrenamiento adecuado para maximizar los resultados.
  3. Realizar ciclos de uso, con períodos de descanso, para evitar la desensibilización del cuerpo al péptido.

Consideraciones finales

El MOD GRF 1-29 de Deus Medical ofrece un enfoque interesante para aquellos que buscan mejorar su rendimiento atlético y sus resultados de entrenamiento. Sin embargo, es fundamental realizar una consulta con un especialista en salud o nutrición antes de iniciar el uso de este tipo de sustancias para asegurar su adecuada implementación y minimizar riesgos.

0
    0
    Vaša košarica
    Košarica je praznaNadaljuj nakup
    Nadaljuj nakup
      Izračunaj dostavo
      Uporabi kupon
      Scroll to Top